Back to JournalPrivate-Market Secondaries and Liquidity

How Secondaries Can Reduce the J-Curve for PE and VC Investors

Urvashi L1 min read

Understanding the Secondary Transaction

The J-curve describes a private-market fund's typical early trajectory: negative net cash flow in the first years as fees are charged and capital is deployed, before distributions eventually turn the curve positive. Secondaries can shorten this experience for a buyer by entering after some of the early period has already passed.

Reading Price, Portfolio and Obligations

A buyer purchasing a secondary in a fund's fourth or fifth year, for instance, may skip the deepest, earliest part of the J-curve and enter closer to when distributions typically begin to accelerate — reducing both the duration and depth of negative cash flow they personally experience.

Where Secondary Liquidity Breaks

This benefit is not automatic — it depends entirely on price and the remaining portfolio's actual trajectory. Overpaying for a seasoned secondary position can erase the J-curve benefit entirely, and adverse selection (a seller exiting because the portfolio's remaining trajectory looks weak) can turn an apparent J-curve improvement into a worse overall outcome.

Making the Purchase or Sale Decision

Before relying on J-curve mitigation as a reason to buy a secondary, confirm the price paid genuinely reflects a discount to fair value (not just a discount to a stale NAV), and independently assess the remaining portfolio's actual distribution trajectory rather than assuming a shorter J-curve automatically follows from a later entry point.

A secondary can meaningfully reduce J-curve exposure, but only when the price is genuinely fair and the remaining portfolio's trajectory is independently verified, not assumed.

Key takeaways

  • The J-curve is the typical early negative-cash-flow pattern of private-market funds before distributions begin.
  • Buying a secondary later in a fund's life can skip the deepest, earliest part of this pattern.
  • The benefit is not automatic — overpaying or adverse selection can erase it entirely.
  • Independently assess the remaining portfolio's actual trajectory rather than assuming J-curve reduction follows automatically.

Related questions

What should an investor verify first?

Whether the price paid genuinely reflects a discount to fair value, not just a discount to a stale NAV.

Which documents matter most?

The remaining portfolio's actual distribution history and forward trajectory, independently assessed.

What is the main downside to test?

Assuming J-curve reduction follows automatically from a later entry point, regardless of price paid.

How should the final decision be made?

Confirm both fair pricing and a genuinely healthy remaining portfolio before relying on J-curve mitigation.

Need personalized advice?

Schedule a conversation about your private market allocation goals.

Request an advisory call